Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01924975 · ClinicalTrials.gov registry record · NA
Saphenous Vein Cannulation in Infants and Small Children
A NA study of Saphenous Vein Cannulation, sponsored by Satoshi Hanada.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
- 1
- Study location
NCT01924975 is a NA study of Saphenous Vein Cannulation that has completed, run by Satoshi Hanada. The registered enrollment target is 102 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01924975, a NA study of Saphenous Vein Cannulation, has completed, sponsored by Satoshi Hanada.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the two different saphenous vein cannulation techniques; real-time ultrasound image-guided technique (Ultrasound group) vs. traditional landmark technique (Landmark group).
Conditions Studied
Interventions
- PROCEDURE Saphenous vein cannulation
- DEVICE ultrasound with a linear transducer (L15-7io)
- DEVICE A 22 or 24 G intravenous catheter
Study Locations (1)
Iowa
- University of Iowa Hospitals & Clinics - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01924975
The ClinicalTrials.gov registry entry for NCT01924975 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Satoshi Hanada, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Saphenous Vein Cannulation appearing as the primary indexed condition, and to 3 interventions - of which Saphenous vein cannulation is the first listed.
NCT01924975 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT01924975 about?
NCT01924975 is a clinical study titled "Saphenous Vein Cannulation in Infants and Small Children". The purpose of this study is to compare the two different saphenous vein cannulation techniques; real-time ultrasound image-guided technique (Ultrasound group) vs. traditional landmark technique (Landmark group).
What is the current status of trial NCT01924975?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2013-07. Estimated completion is 2014-07.
What conditions does trial NCT01924975 study?
This clinical trial studies the following conditions: Saphenous Vein Cannulation.
What interventions are being tested in trial NCT01924975?
The interventions under investigation include: Saphenous vein cannulation (PROCEDURE), ultrasound with a linear transducer (L15-7io) (DEVICE), A 22 or 24 G intravenous catheter (DEVICE).
Who is sponsoring clinical trial NCT01924975?
This trial is sponsored by Satoshi Hanada, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01924975 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.